StockWatch
·
Biological Products, (No Diagnostic Substances)
Corporate ActionJun 5, 2026, 04:37 PM

BiomX Issues 1.01M Shares from Convertible Note Conversion

AI Summary

BiomX Inc. issued 1,013,637 restricted shares of common stock to three assignees on June 2, 2026. This issuance resulted from the partial conversion of an outstanding convertible promissory note, originally issued to Mandragola Ltd., involving approximately $379,000 in principal. The note is part of a previously disclosed $2,000,000 revolving Line of Credit Agreement with Mandragola Ltd. Additionally, BiomX issued a five-year warrant to Mandragola to purchase up to 2,000,000 shares at an exercise price of $12.00 per share, contingent on stockholder approval. Following this transaction, the company has 11,160,153 shares of common stock issued and outstanding.

Key Highlights

  • BiomX Inc. issued 1,013,637 restricted shares of common stock.
  • Shares were issued upon partial conversion of a convertible promissory note.
  • Approximately $379,000 in principal from the note was converted.
  • The note is part of a $2,000,000 revolving Line of Credit Agreement with Mandragola Ltd.
  • BiomX also issued a five-year warrant to Mandragola to purchase up to 2,000,000 shares.
  • The warrant exercise price is $12.00 per share, subject to stockholder approval.
  • Total outstanding shares after this issuance are 11,160,153.